The genetically engineered food experiment has finally been met with massive resistance — more than 20 years since GMOs hit the market.
People didn’t quite know what they were buying, or biting into, until recently thanks in large part to the alternative media and mass social media movement exposing the truth.
As the strange and mostly untested (especially long-term) science of tampering with genes in a lab continues, however, it’s fair to wonder whether a similar scenario might play itself out with a new experimental type of medical treatment.
Dubbed “immunoprophalaxis by gene transfer,” scientists have reportedly used it to target and inactivate the HIV virus in monkeys, according to an article from the New York Times.
But What Are the Side Effects?
The article reads like a classic fluff piece on the mainstream medical community and its “advancements” which oftentimes seem to culminate only in more dangerously untested and extravagantly priced drugs even after millions are spent on research.
Only this time, the stakes could be even higher.
The new type of gene transfers could reportedly “re-engineer animals to resist disease” according to the Times article, including “ebola, malaria, flu and hepatitis.”
It involves producing artificial genes that contain disease-fighting antibodies.
But could such a treatment really succeed where vaccines have failed, or is it just another case of scientists playing God in areas where it isn’t needed?
Once again, science appears to be ignoring the myriad cases of people who have healed, reversed, and prevented such diseases in favor of a highly convoluted and highly expensive process that could bring a huge payday and notoriety down the line, even if it ends up being proven dangerous.
According to the chief CEO of one major pharmaceutical company, this new I.G.T. Therapy could potentially replace vaccines down the line.
But who will ensure its safety, and is science going too far yet again? Read the Times piece by clicking here, stay tuned for more news, and decide for yourself.
One scientific paper published in the British Medical Journal in 2005 has already raised serious health concerns over the safety of human gene transfer treatments including possible leukemia risks, although the assessments were done on prior types of treatments.
Either way this is certainly a development worth watching.